MET and neoplasm: Aberrant HGF/c-Met axis activation promotes tumor development and progression in cancer cells by activating the phosphatidylinositol-3 kinase (PI3K)/Akt, Ras/mitogen-activated protein kinase (MAPK) pathway and other signaling pathways [7].